TGA Approval

OMVOH mirikizumab 100 mg/mL + 200 mg/2 mL solution for injection pre-filled syringe (composite pack) (citrate free formulation) (461265)

ARTG ID

461265

ARTG Name

OMVOH mirikizumab 100 mg/mL + 200 mg/2 mL solution for injection pre-filled syringe (composite pack) (citrate free formulation)

Sponsor

Eli Lilly Australia Pty Ltd

ARTG Date

July 4, 2025

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Eli Lilly Australia Pty Ltd

Sponsor Item Name

ELI LILLY AUSTRALIA PTY LTD

Active Ingredients

Ingredient Name

mirikizumab

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

OMVOH mirikizumab 100 mg/mL + 200 mg/2 mL solution for injection pre-filled syringe (composite pack) (citrate free formulation) (461265) - TGA 批准文号 | MedPath

AI-Powered Research

Premium Access

OMVOH mirikizumab 100 mg/mL + 200 mg/2 mL solution for injection pre-filled syringe (composite pack) (citrate free formulation) (461265)

Sponsor Information

Active Ingredients

MedPath

Product

Company

Legal